13G Filing: Camber Capital Management and Tenet Healthcare Corp (THC)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 6 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE......(read more)
Posts Tagged ‘Hedge Fund:499’
13G Filing: Camber Capital Management and AMAG Pharmaceuticals Inc. (AMAG)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 6 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE......(read more)
13G Filing: Camber Capital Management and Amag Pharmaceuticals Inc. (AMAG)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 6 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE......(read more)
13G Filing: Camber Capital Management and Amag Pharmaceuticals Inc. (AMAG)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 6 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE......(read more)
Ptc Therapeutics Inc. (PTCT): Camber Capital Management Adds 500,000 Shares to Its Position
Stephen DuBois‘ Camber Capital Management recently filed a Form 13G with the SEC, in which it reported raising its stake in Ptc Therapeutics Inc......(read more)
Carl Icahn Can’t Stop Buying Cheniere; Nelson Peltz Boosts Stake In SYSCO
Most individual investors already know the value of monitoring activist investors, who generally make value-enhancing proposals or push for changes at......(read more)
Elite Hedge Funds’ Bullish Moves On These Four Stocks
The latest round of 13F filings kicked off at the beginning of October, but as these public filings are only required to be filed within 45 days of the......(read more)
Pfizer Inc (PFE) Made Protalix BioTherapeutics, Inc. (PLX) Jump 11% Today
Camber Capital filed an amended 13G on Protalix BioTherapeutics (NYSE:PLX) today disclosing a large increase in its position. Stephen Dubois’ hedge......(read more)
Sequenom, Aclaris, and Xenoport Making Waves Among Elite Healthcare Investors
Three prominent healthcare-focused funds that we track at Insider Monkey submitted filings with the SEC today, disclosing new or bulked up positions in......(read more)
Camber Capital Quick To Move On This Newly-Listed Biotech Stock
According to a recent filing with the Securities and Exchange Commission, Stephen DuBois‘s Camber Capital Management initiated a position in the......(read more)
Healthcare-Focused Fund Camber Capital’s Top Picks: Masimo Corporation (MASI), The Medicines Company (MDCO)
Camber Capital Management is a hedge fund headquartered in Boston and founded by Stephen DuBois. The hedge fund is considered as an activist due to activist......(read more)
Epirus Biopharmaceuticals Inc (EPRS): These Two Funds Open New Positions
The days of having no fund activity in Epirus Biopharmaceuticals Inc (NASDAQ:EPRS) are over. In filings with the SEC that were revealed over the last......(read more)
3 Stocks Hedge Funds Just Bought; Should You?
We have a trifecta of recent hedge fund buying activity for you to digest, featuring three different funds and three different stocks. We’ll kick it......(read more)
Masimo Corporation (MASI): Camber Capital Management Ups Passive Position to 5.5%
Stephen DuBois‘ Camber Capital Management has reported raising its passive position in Masimo Corporation (NASDAQ:MASI). As a new filing with......(read more)
Universal American Corporation (UAM): Camber Capital Management Resumes Buying Shares
Stephen Dubois’ Camber Capital Management is again increasing its stakes in Universal American Corporation (NYSE:UAM). Camber Capital Management’s......(read more)
Volcano Corporation (VOLC): Camber Capital Takes 9.81% Stake
Stephen Dubois’ Camber Capital Management has disclosed in a regulatory filing with Security and Exchange Commission a stake of 9.81% in medical equipment......(read more)
Orthofix International NV (OFIX): Stephen Dubois Surges His Stake Amid Company’s Financial Statements Issues
As a new filing with the Securities and Exchange Commission showed, Camber Capital Management surged its exposure to Orthofix International NV (NASDAQ......(read more)
Camber Capital Management Adds To Position In Genomic Health, Inc. (GHDX)
Stephen Dubois is optimistic about the prospects of Genomic Health, Inc. (NASDAQ:GHDX) and has increased his fund’s holding of the stock. As reported......(read more)
Camber Capital Surges Stake In Sequenom Inc. (SQNM) To Over 5%
Camber Capital Management, managed by Stephen Dubois, is bullish on Sequenom Inc. (NASDAQ:SQNM). In a new filing with the Securities and Exchange Commission......(read more)
Camber Capital Management Reveals New Position in Cardica, Inc. (CRDC)
Stephen Dubois‘ Camber Capital Management revealed a new stake in Cardica, Inc. (NASDAQ:CRDC). According to a recent 13G filing, the fund now......(read more)
Hedge Fund News: John Paulson, Ray Dalio & Paul Singer
Paulson moves on from sour euro bets (Financial News) The European unit of US hedge fund firm Paulson & Co, which is run by billionaire investor ......(read more)
Camber Capital Raises Exposure to CONMED Corporation (CNMD)
Stephen DuBois‘ Camber Capital has raised its holding in CONMED Corporation (NASDAQ:CNMD). The fund revealed holding almost 1.4 million shares......(read more)
Stephen DuBois’s Hedge Fund Now Owns a Large Position in Ariad Pharmaceuticals
Stephen DuBois, Ariad Pharmaceuticals: In a new filing just reported to the SEC, Stephen DuBois‘s Camber Capital disclosed a new 5.4% stake in ......(read more)
Camber Capital Takes Big Position in Med-Tech Company Biolase
Camber Capital Management, a hedge fund managed by Stephen Dubois recently disclosed adding a new position to its equity portfolio, BIOLASE Inc (NASDAQ......(read more)
Hedge Funds Are Selling Humana Inc (HUM)
Humana Inc (NYSE:HUM) has made any of its supporters look smart for some time now. But nothing lasts forever. One indicator suggests that profit-taking......(read more)
